Issues for new antiepilepsy drug development

摘要

Purpose of reviewPreclinical research in epileptology has been very successful in producing effective drugs. Unfortunately, however, seizures are still not adequately controlled in a third of the affected individuals, and comorbidities still impose a major burden on quality of life. New preclinical and clinical drug development strategies are needed to identify drugs that target these unmet medical needs.